Efficacy of Intramammary Tilmicosin at Drying-off, and Other Risk Factors, for Prevention of New Intramammary Infections during the Dry Period

Authors

  • R. T. Dingwell University of Guelph, Ontario, Canada N1G 2W1
  • T. F. Duffield University of Guelph, Ontario, Canada N1G 2W1
  • E. Leslie University of Guelph, Ontario, Canada N1G 2W1
  • G. P. Keefe University of Prince Edward Island, Canada
  • L. DesCôteaux University of Montreal, Canada
  • D. F. Kelton University of Guelph, Ontario, Canada N1G 2W1
  • K. D. Lissemore University of Guelph, Ontario, Canada N1G 2W1
  • Y. H. Schukken Cornell University, Ithaca, NY

DOI:

https://doi.org/10.21423/aabppro20025083

Keywords:

intramammary infusion, tilmicosin phosphate, placebo, intramammary infections

Abstract

This study compared the efficacy of an intramammary infusion containing tilmicosin phosphate to an infusion of a negative-control intramammary placebo for preventing new intramammary infections (IMI) during the dry period.

Downloads

Published

2002-09-26

Issue

Section

Posters

Most read articles by the same author(s)

1 2 3 4 5 > >>